BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1151724)

  • 1. Fluorinated quinazolones III: synthesis and CNS depressant activity of fluorinated quinazolone derivatives.
    Joshi KC; Singh VK; Mehta DS; Sharma RC; Gupta L
    J Pharm Sci; 1975 Aug; 64(8):1428-30. PubMed ID: 1151724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorinated quinazolones: synthesis & CNS activity of fluorinated quinazolone derivatives.
    Joshi KC; Dubey K; Barthwal JP
    Indian J Exp Biol; 1977 Nov; 15(11):1064-6. PubMed ID: 614189
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and central nervous system activity of quinazolones related to 2-methyl-3-(o-tolyl)-4(3H)-quinazolone (methaqualone).
    Ager IR; Harrison DR; Kennewell PD; Taylor JB
    J Med Chem; 1977 Mar; 20(3):379-86. PubMed ID: 845871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and central nervous system depressant activity of some 2-aryl-6-chloro-4-phenylquinazolines.
    Kohl H; de Souza NJ; Desai PD
    J Med Chem; 1973 Sep; 16(9):1045-7. PubMed ID: 4745507
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorinated quinazolones: effect of some fluorinated 2-alkyl-3-aryl-4(3H)-quinazolones & thioquinazolones on pyruvic acid oxidation in rat brain homogenates.
    Narayanan A; Pradet A
    Indian J Exp Biol; 1974 May; 12(3):286-7. PubMed ID: 4448485
    [No Abstract]   [Full Text] [Related]  

  • 6. CNS-depressant activity of some newly synthesised 4(3H)-quinazolones.
    Mukerji DD; Nautiyal SR; Prasad CR; Dhawan BN
    Indian J Med Res; 1980 Mar; 71():480-2. PubMed ID: 7390588
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of some 2,3-disubstituted quinazolones as possible anticonvulsants.
    Misra VS; Pandey RN; Dua PR
    Pol J Pharmacol Pharm; 1978; 30(4):573-7. PubMed ID: 740559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant and some neuropharmacological properties of 2-methyl-3-omicron-tolyl-6-chloro-4(3h)-quinazolone and related compounds.
    Mehta VL; Malhotra CL
    J Pharm Pharmacol; 1966 Aug; 18(8):536-9. PubMed ID: 4381859
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP; Tandon SK; Agarwal VK; Dixit KS; Parmar SS
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between CNS depressant activity and selective enzyme inhibition by quinazolone salicylhydrazide derivatives.
    Gupta TK; Kumar R; Ali B; Parmar SS
    Jpn J Pharmacol; 1973 Feb; 23(1):5-8. PubMed ID: 4541619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis of potential CCK antagonist quinazolone derivatives].
    Szabó M; Kökösi J; Orfi L
    Acta Pharm Hung; 1995 Jul; 65(4):133-8. PubMed ID: 7572196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazolinones. 19. Communication [1]: synthesis and evaluation of some CNS depressant properties of 3-(2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido)-2-methyl-4 (3H)-quinazolinones.
    Ergenç N; Büyüktimkin S; Capan G; Baktir G; Rollas S
    Pharmazie; 1991 Apr; 46(4):290-1. PubMed ID: 1886919
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis of potential CCK antagonist quinazolone derivatives. II].
    Szabó M; Kökösi A; Kovács A; Orfi L
    Acta Pharm Hung; 1995 Sep; 65(5):175-81. PubMed ID: 7484165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and CNS-pharmacological properties of two hydrosoluble benzodiazepine derivatives.
    Babbini M; De Marchi F; Montanaro N; Strocchi P; Torrielli MV
    Arzneimittelforschung; 1969 Dec; 19(12):1931-6. PubMed ID: 5395885
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzimidazolyl-1,2,4(H)-triazoles as central nervous system depressants.
    Parmar SS; Gupta AK; Singh HH; Gupta TK
    J Med Chem; 1972 Sep; 15(9):999-1000. PubMed ID: 5051021
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs acting on the central nervous system. Syntheses of substituted quinazolones and quinazolines and triazepino- and triazocinoquinazolones.
    Gupta CM; Bhaduri AP; Khanna NM
    J Med Chem; 1968 Mar; 11(2):392-5. PubMed ID: 5663640
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropharmacological activities of the crude alkaloidal fraction from stems of Tabernaemontana pandacaqui Poir.
    Taesotikul T; Panthong A; Kanjanapothi D; Verpoorte R; Scheffer JJ
    J Ethnopharmacol; 1998 Oct; 62(3):229-34. PubMed ID: 9849633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and central nervous system depressant activity of new piperazine derivatives. I.
    Petigara RB; Deliwala CV; Mandrekar SS; Sheth UK
    J Med Chem; 1968 Mar; 11(2):332-6. PubMed ID: 5663626
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and evaluation of substituted 4(3H)-quinazolone derivatives for antimicrobial and antiacetylcholinesterase activities. Part 3.
    Misra HK; Sen Gupta AK
    Pharmazie; 1982 Apr; 37(4):254-6. PubMed ID: 7100248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.